Suppr超能文献

[格兰达辛在神经症治疗中的应用经验]

[Experience with the therapeutic use of grandaxin in neuroses].

作者信息

Kostiunina Z G, Eletskiĭ V Iu

出版信息

Zh Nevropatol Psikhiatr Im S S Korsakova. 1982;82(4):117-20.

PMID:6124072
Abstract

The use of the drug grandaxin (made in Hungary) has demonstrated its high activity in the treatment of psychopathological disturbances of neurotic origin. Its administration is preferable when vegetative and hyposthenic disturbances are prevalent in the neurosis clinical picture. At the same time it alleviates the intensity of phobic and senestho-hypochondriacal experiences, however, its administration as the sole means for eliminating these disturbances seems undesirable. Neither can grandaxin be the drug of choice in controlling anxious and agrypnic disturbances. Psychogenic somatic syndromes have also appeared to be insensitive to the treatment with this drug. The side-effects produced by grandaxin are mild. The most persistent are nausea and headaches which develop in patients receiving high doses and subside in most cases spontaneously on reduction of the latter. No complications were noted.

摘要

使用匈牙利生产的药物格兰达新已证明其在治疗神经症性精神病理障碍方面具有高活性。当神经症临床表现中以植物神经紊乱和体力衰弱为主时,使用该药较为适宜。同时,它可减轻恐惧及疑病性体验的强度,然而,将其作为消除这些障碍的唯一手段似乎并不理想。格兰达新也不是控制焦虑和失眠障碍的首选药物。心因性躯体综合征似乎对该药治疗也不敏感。格兰达新产生的副作用较轻。最常见的是恶心和头痛,在接受高剂量治疗的患者中出现,大多数情况下在减少剂量后会自行缓解。未发现并发症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验